Skip to content
Unrated Drug recall · FDA · Published May 31, 2023

ZIPRASIDONE Capsules 20mg: Label Mix-Up Risk

Major Pharmaceuticals recalls 20mg Ziprasidone capsules due to label mix-up with Dronabinol capsules. Affected units contain incorrect medication. Consumers should check product details and contact for guidance.

🇺🇸 FDA recall #D-0893-2023DrugMajor Pharmaceuticals ›
Take action

Contact the company

Recalling firmThe Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories341 Mason Rd · La Vergne, TN 37086-3606
✎ GovInfoNow plain-language explainer

Major Pharmaceuticals is recalling 20mg Zipras: 20mg Ziprasidone capsules that were labeled incorrectly with Dronabinol capsules. This mix-up could lead to taking the wrong medication, which may cause serious health issues. Read more at govinfonow.com/recall/33425-ziprasidone-capsules-20mg-label-mix-up-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/33425-ziprasidone-capsules-20mg-label-mix-up-risk · Updated September 23, 2026 · FDA enforcement record: FDA #D-0893-2023

Cite this page

“ZIPRASIDONE Capsules 20mg: Label Mix-Up Risk.” GovInfoNow, updated September 23, 2026. https://govinfonow.com/recall/33425-ziprasidone-capsules-20mg-label-mix-up-risk. Based on FDA recall #D-0893-2023 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0893-2023%22&limit=1).

The FDA announced on May 31, 2023, that The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories voluntarily recalled Ziprasidone Hydrochloride Capsules 20 mg due to a labeling mix-up. Unit dose cartons labeled as the prescribed drug were found to contain Dronabinol Capsules instead.

How to tell if you have it

  • Brand: Major Pharmaceuticals
  • Product: ZIPRASIDONE HYDROCHLORIDE CAPSULES 20 mg, Unit Dose Carton 40 Capsules
  • NDC: 0904-6269-08
  • Lot: T04769
  • Expiration: 2024/12
  • Manufacturer: Dr. Reddy's Laboratories Limited
  • Distributor: Major Pharmaceuticals, Livonia, MI
  • Distribution: Nationwide in the USA

The hazard

The hazard is a labeling mix-up where unit dose cartons labeled as Ziprasidone Hydrochloride Capsules, 20 mg contained blister packages labeled as and containing Dronabinol Capsules, USP, 2.5 mg.

Context

GovInfoNow's records show The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories has 14 other recalls on record since October 23, 2023. Other recent recalls of similar products include Major Chlorpromazine 50mg Tablets Recall (September 12, 2025), Major Pharmaceuticals Sulfamethoxazole-Trimethoprim Recall (September 2, 2025), and Major Pharmaceuticals Carvedilol Tablets Recall (August 20, 2025). Other recent recalls of similar products include American Health Packaging Buprenorphine Tablets Recall (August 19, 2026), Ajanta Pharma Aripiprazole Tablets 30mg (May 27, 2026), and Hikma Ramipril Capsules 10mg Recall (August 24, 2026).

How to tell if you have this one

Check for the product name 'ZIPRASIDONE HYDROCHLORIDE CAPSULES 20 mg' on the unit dose carton. The product was manufactured by Dr. Reddy's Laboratories in India and distributed by Major Pharmaceuticals in the US.

  • Brand
    Major Pharmaceuticals
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Label

    Look for the product name 'ZIPRASIDONE HYDROCHLORIDE CAPSULES 20 mg' on the unit dose carton.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 13 months after the firm started it.

1. Firm started the recall: May 31, 202312. Published in FDA’s Enforcement Report: Jun 28, 202323. FDA classified it Class I: Jul 5, 202334. FDA terminated the recall: Jul 2, 2024420232024
  1. Firm started the recall
  2. Published in FDA’s Enforcement Report
  3. FDA classified it Class I
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0893-2023 (May 31, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0893-2023 to see it in context.
  • Plain-language summary written by qwen3:4b on September 23, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA